Morena Miciaccia is a Researcher in Medicinal Chemistry at the Department of Pharmacy–Pharmaceutical Sciences, University of Bari (Italy). Her main research interests focus on the "in vitro" biopharmaceutical evaluation of compounds with potential applications in oncology. Currently, she is developing agnostic drug candidates for Diffuse Midline Glioma, which is a rare and aggressive brain tumor for which at this time there is no efficacious treatment.